Automated technology streamlines astatine-211 production for cancer therapy

Astatine-211 (At-211) is one of a handful of promising alpha emitting radioisotopes for cancer therapy.

Pharmalittle: We’re reading about an AstraZeneca bladder cancer drug, Genentech anxiety, and more

Good morning, everyone, and welcome to another working week. We hope the weekend respite was invigorating and refreshing, because that oh-so familiar routine of online

September 16, 2024

Lecanemab effectively targets amyloid plaques in people with Down syndrome, study finds

People with Down syndrome are likely to develop Alzheimer’s disease at a young age, with autopsy studies showing that by age 40 years, the brains

August 19, 2024

Corrected: Merck KGaA’s mixed Phase 2 lupus results; Zymeworks pauses work on ADC

Plus, news about Tris Pharma and ARS Pharmaceuticals: Merck KGaA’s lupus drug yields mixed data in mid-stage trial: The drugmaker’s TLR7/8 inhibitor, called enpatoran …

March 7, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.